Keeping Track Of Breakthrough Therapy Designations Depression Headaches Hepatitis
Keeping Track Of Breakthrough Therapy Designations: Depression, Headaches, Hepatitis
17:43 EST 18 Nov 2018 |
SCRIP
The latest developments in one of the US FDA's favorite pathways.
More From BioPortfolio on "Keeping Track Of Breakthrough Therapy Designations: Depression, Headaches, Hepatitis"